July 9, 2013
Onglyza Tablets Kyowa Hakko Kirin’s dipeptidyl peptidase-4 (DPP-4) inhibitor Onglyza Tablets 2.5 mg and 5 mg (saxagliptin) went on sale on July 9, marking the company’s entry into the diabetes market. Onglyza is Japan’s seventh DPP-4 inhibitor, with peak sales...read more